Harfst & Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-200
Closed -$16K – 240
2017
Q1
$16K Buy
+200
New +$15.7K 0.01% 199
2016
Q1
– Sell
-1,242
Closed -$110K – 91
2015
Q4
$110K Buy
1,242
+210
+20% +$17.8K 0.04% 129
2015
Q3
$79K Buy
1,032
+630
+157% +$52.6K 0.03% 153
2015
Q2
$34K Buy
+402
New +$35.5K 0.02% 203

Other funds holding CAH

Harfst & Associates's CAH Position: Q2 2017 in Review

Harfst & Associates sold out of Cardinal Health (CAH) in Q2 2017, closing a stake of 200 shares — an estimated $16K sold.

Harfst & Associates first reported a position in CAH in Q2 2015 and held it in 4 quarters. The position peaked at $110K in Q4 2015. 747 funds tracked by Wall St. Rank hold CAH as of Q2 2017.

  • Harfst & Associates reported no remaining Cardinal Health position as of Q2 2017 after selling out during the quarter.
  • Harfst & Associates sold 200 Cardinal Health shares in Q2 2017, an estimated $16K.
  • Harfst & Associates first reported a position in Cardinal Health in Q2 2015 and held it in 4 quarters.
  • Harfst & Associates's Cardinal Health position peaked at $110K in Q4 2015.
  • 747 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2017.

Based on Harfst & Associates's 13F filing for Q2 2017, filed 11 Aug 2017.